Enviroxime is an antiviral agent.[1] It inhibits coxsackievirus B3-, rhinovirus-, or poliovirus-induced plaque formation in HeLa monolayer cell cultures when used at concentrations of 0.1, 1, and 10 &#181g/ml.1 Enviroxime (1 &#181g/ml) inhibits production of poliovirus PV1 viral RNA in HeLa monolayer cell cultures. It reduces viral titers in DRAW macrophages infected with the DA strain of Theiler’s murine encephalomyelitis virus.[2]

Reference:
[1].Heinz, B.A., and Vance, L.M.The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirusJ. Virol.69(7)4189-4197(1995) 2.Steurbaut, S., Merckx, E., Rombaut, B., et al.Modulation of viral replication in macrophages persistently infected with the DA strain of Theiler’s murine encephalomyelitis virusVirol. J.589(2008)